Cyclosporine In Takotsubo Syndrome
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 204 participants.
Also called NCT05946772
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 204 participants
- Registry
-
NCT05946772
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Germany
- Registry status
- Recruiting
Technical summary
Registry record NCT05946772. Randomized; quadruple masking; primary purpose treatment. Start 2025-02-01 (actual); primary completion 2027-02 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Cyclosporine In Takotsubo Syndrome
- Acronym
- CIT
- Condition
- Takotsubo Cardiomyopathy
- Intervention (Drug)
- Cyclosporine A
- Intervention (Drug)
- Placebo
- Lead sponsor
- University Hospital Heidelberg
- Collaborator
- German Centre of Cardiovascular Research (DZHK)
- Collaborator
- Coordinating Centre for Clinical Studies (KKS) Heidelberg
Record details
- Record id
cardio:ct-nct05946772- Content hash
3598454fb305ed53571c4e5fedaebf2343bb4d2fa56a65be27fba3a58482e1cc